欧洲卒中诊断市场，按严重程度（中度、重度、轻度）、类型（计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT)、其他）、应用（缺血性卒中、出血性卒中、短暂性脑缺血发作 (TIAS)）、最终用户（医院、诊所、门诊手术中心、家庭医疗保健）、分销渠道（直接招标、第三方分销商、其他）、阶段（术前、术中、术后）、国家（德国、法国、英国、意大利、西班牙、俄罗斯、荷兰、瑞士、土耳其、奥地利、比利时和欧洲其他地区）、行业趋势和预测到 2028 年
市场分析与洞察：欧洲中风诊断市场
预计欧洲中风诊断市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2021 年至 2028 年的预测期内，市场将以 6.0% 的复合年增长率增长，预计到 2028 年将达到 13.7771 亿美元。产品开发的增加和早期诊断需求的增加是推动预测期内市场需求的主要驱动因素。然而，严格的法规可能会阻碍市场增长。
当脑部血液供应减少或完全受阻时，就会发生中风，导致脑组织无法获得氧气和营养。目前有多种诊断设备可用于检测中风及其早期症状，例如计算机断层扫描 (CT SCAN)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声等。
中风、心血管和神经系统疾病的发病率不断上升，增加了发展中国家对中风诊断的需求。此外，医疗支出的增加也推动了市场的增长。另一方面，诊断的高成本可能会阻碍市场的增长。市场参与者的存在和新产品的推出为市场提供了机会。然而，缺乏熟练的专业人员可能会给市场带来挑战。
中风诊断市场报告提供了市场份额、新发展、国内和本地市场参与者的影响、新兴收入领域机会分析、市场法规变化、产品审批、战略决策、产品发布、地域扩张和市场技术创新的详细信息。要了解分析和市场情况，请联系我们获取分析师简报。我们的团队将帮助您创建收入影响解决方案，以实现您的预期目标。
欧洲中风诊断市场范围和市场规模
欧洲中风诊断市场根据严重程度、类型、应用、最终用户、分销渠道和阶段分为六个显著的细分市场。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
- 根据严重程度，欧洲中风诊断市场分为中度、重度和轻度。2021 年，由于医疗支出和医疗设施的增加，中度中风预计将占据市场主导地位。
- 根据类型，欧洲中风诊断市场细分为计算机断层扫描 (CT 扫描)、计算机断层血管造影 (CTA)、磁共振成像 (MRI)、磁共振血管造影 (MRA)、经颅多普勒超声、视频头部脉冲测试 (VHIT) 和其他。随着技术的不断进步，预计 2021 年计算机断层扫描 (CT 扫描) 领域将占据市场主导地位，可在更短的时间内提供准确的结果。
- 根据应用，欧洲中风诊断市场分为缺血性中风、出血性中风和短暂性脑缺血发作 (TIAS)。随着中风诊断技术的不断增强，预计到 2021 年，缺血性中风将占据市场主导地位。
- 根据最终用户，欧洲中风诊断市场分为医院、家庭医疗保健、门诊手术中心和诊所。预计到 2021 年，医院部门将占据市场主导地位，拥有所有诊断设备。
- 根据分销渠道，欧洲中风诊断市场分为直接招标、第三方分销商和其他。由于存在各种主要市场参与者，预计 2021 年直接招标将占据市场主导地位。
- 根据阶段，欧洲中风诊断市场分为术前、围手术期和术后。由于中风和心血管疾病的发病率不断上升，预计 2021 年术前诊断将占据市场主导地位。
欧洲中风诊断市场国家级分析
对欧洲中风诊断市场进行了分析，并将市场规模信息分为六个值得关注的部分，即严重程度、类型、应用、最终用户、分销渠道和阶段。
中风诊断市场报告涉及的国家包括德国、英国、法国、意大利、西班牙、荷兰、俄罗斯、瑞士、比利时、土耳其、奥地利、挪威、匈牙利、立陶宛、爱尔兰、波兰和欧洲其他地区。
由于对中风诊断的需求不断增长，预计欧洲地区的中风诊断领域将在 2021 年至 2028 年的预测期内以最高增长率增长。由于医疗保健行业研发的增长，预计德国将主导欧洲中风诊断市场。
报告的国家部分还提供了影响单个市场因素和国内市场监管变化，这些因素和变化会影响市场的当前和未来趋势。新销售、替代销售、国家人口统计、监管法案和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了欧洲品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀少竞争而面临的挑战、销售渠道的影响。
医疗支出的增加推动了中风诊断市场的增长
中风诊断市场还为您提供每个国家中风诊断行业增长的详细市场分析，包括中风诊断药物销售、中风诊断技术进步的影响以及监管环境的变化及其对中风诊断市场的支持。数据涵盖 2010 年至 2019 年的历史时期。
竞争格局和中风诊断市场份额分析
中风诊断市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、生产基地和设施、公司优势和劣势、产品发布、产品试验渠道、产品批准、专利、产品宽度和广度、应用主导地位、技术生命线曲线。以上提供的数据点仅与公司对中风诊断市场的关注有关。
参与欧洲中风诊断市场的主要公司包括荷兰皇家飞利浦公司、史赛克、豪洛捷公司、ESAOTE SPA、岛津制作所、Aspect Imaging 有限公司、西门子、东软集团、Medfield diagnostics AB、富士胶片控股公司、通用电气公司、ALPINION MEDICAL SYSTEMS 有限公司、深圳迈瑞生物医疗电子股份有限公司、Analogic 公司、锐珂医疗、BPL Medical Technologies、IMRIS、Deerfield Imaging 公司、佳能公司、三星、SternMed GmbH 等。
全球各地的公司也发起了许多产品发布和协议，这也加速了中风诊断市场的发展。
例如，
- 2021 年 5 月，西门子宣布推出新款 Somatom X.ceed1，这是一款专为最具挑战性的临床领域设计的新型高分辨率、高速 CT（计算机断层扫描）扫描仪。它为公司的产品线增添了新的内容
- 2021 年 7 月，荷兰皇家飞利浦公司宣布与 Cognizant 合作开发端到端数字健康解决方案，使医疗保健组织和生命科学公司能够改善患者护理并加速临床试验。这将增强他们的技术进步并增加他们的销售额
市场参与者的合作、产品发布、业务扩展、奖励和认可、合资企业和其他策略正在增强公司在中风诊断市场中的市场，这也为组织改善其在中风诊断方面的产品提供了好处。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE STROKE DIAGNOSTICS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 EPIDEMIOLOGY
6 EUROPE STROKE DIAGNOSTICS MARKET: REGULATIONS
6.1 REGULATION IN THE U.S.
6.2 REGULATION IN EUROPE
6.3 REGULATION IN CHINA
6.4 REGULATION IN JAPAN
6.5 REGULATION IN SOUTH AFRICA
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 TECHNOLOGICAL ADVANCEMENT
7.1.2 INCREASE IN THE INCIDENCE OF STROKE
7.1.3 INCREASE IN THE GERIATRIC POPULATION
7.1.4 INCREASE IN NUMBER OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASES
7.2 RESTRAINTS
7.2.1 HIGH COST OF DIAGNOSIS
7.2.2 INCREASE IN PRODUCT RECALL
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE SPENDING
7.3.2 INCREASE IN DIABETIC POPULATION AND OBESITY
7.3.3 INCREASE IN FDA APPROVAL AND PRODUCT LAUNCH
7.3.4 RISE IN AWARENESS REGARDING HEALTH AND STROKE
7.4 CHALLENGES
7.4.1 UNFAVORABLE REIMBURSEMENT SCENARIO
7.4.2 COMPLICATION RELATED TO DIAGNOSTIC DEVICES
8 IMPACT OF COVID-19 ON EUROPE STROKE DIAGNOSTICS MARKET
8.1 IMPACT ON PRICE
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC INITIATIVES
8.5 CONCLUSION
9 EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY
9.1 OVERVIEW
9.2 MODERATE
9.3 SEVERE
9.4 MILD
10 EUROPE STROKE DIAGNOSTICS MARKET, BY TYPE
10.1 OVERVIEW
10.2 COMPUTED TOMOGRAPHY (CT SCAN)
10.3 COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA)
10.4 MAGNETIC RESONANCE IMAGING (MRI)
10.5 MAGNETIC RESONANCE ANGIOGRAPHY (MRA)
10.6 TRANSCRANIAL DOPPLER ULTRASOUND
10.7 VIDEO HEAD IMPULSE TEST (VHIT)
10.8 OTHERS
10.8.1 CAROTID ULTRASOUND
10.8.2 CAROTID ANGIOGRAPHY
10.8.3 ELECTROCARDIOGRAPHY (EKG)
10.8.4 ECHOCARDIOGRAPHY
10.8.5 BLOOD TESTS
10.8.6 NUCLEAR NEUROIMAGING
10.8.7 OTHERS
11 EUROPE STROKE DIAGNOSTICS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 ISCHEMIC STROKE
11.2.1 THROMBOTIC STROKES
11.2.2 EMBOLIC STROKES
11.3 HEMORRHAGIC STROKE
11.3.1 INTRACEREBRAL HEMORRHAGE
11.3.2 SUBARACHNOID HEMORRHAGE
11.4 TRANSIENT ISCHEMIC ATTACKS (TIAS)
12 EUROPE STROKE DIAGNOSTICS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 CLINICS
12.4 AMBULATORY SURGICAL CENTERS
12.5 HOME HEALTHCARE
12.6 OTHERS
13 EUROPE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 THIRD PARTY DISTRIBUTORS
13.4 OTHERS
14 EUROPE STROKE DIAGNOSTICS MARKET, BY STAGE
14.1 OVERVIEW
14.2 PRE OPERATIVE
14.3 PERI OPERATIVE
14.4 POST OPERATIVE
15 EUROPE STROKE DIAGNOSTICS MARKET, BY REGION
15.1 EUROPE
15.1.1 GERMANY
15.1.2 FRANCE
15.1.3 U.K.
15.1.4 ITALY
15.1.5 SPAIN
15.1.6 RUSSIA
15.1.7 NETHERLANDS
15.1.8 SWITZERLAND
15.1.9 TURKEY
15.1.10 AUSTRIA
15.1.11 BELGIUM
15.1.12 REST OF EUROPE
16 STROKE DIAGNOSTICS MARKET COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: EUROPE
17 SWOT ANALYSIS
18 COMPANY PROFILE
18.1 SIEMENS
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 KONINKLIJKE PHILIPS N.V.
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 COMPANY SHARE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPMENTS
18.3 GENERAL ELECTRIC COMPANY
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 CANON INC
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 ALPINION MEDICAL SYSTEMS CO., LTD
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENTS
18.7 ANALOGIC CORPORATION
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENT
18.8 ASPECT IMAGING LTD
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENT
18.9 BPL MEDICAL TECHNOLOGIES
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENT
18.1 CARESTREAM HEALTH
18.10.1 COMPANY SNAPSHOT
18.10.2 REVENUE ANALYSIS
18.10.3 PRODUCT PORTFOLIO
18.10.4 RECENT DEVELOPMENTS
18.11 ESAOTE SPA
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 FONAR CORP
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 FUJIFILM HOLDINGS CORPORATION
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 HOLOGIC, INC
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENTS
18.15 IMRIS, DEERFIELD IMAGING INC.
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 MEDFIELD DIAGNOSTICS AB
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 MEDTRON AG
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENT
18.18 NEUSOFT CORPORATION
18.18.1 COMPANY SNAPSHOT
18.18.2 REVENUE ANALYSIS
18.18.3 PRODUCT PORTFOLIO
18.18.4 RECENT DEVELOPMENT
18.19 SAMSUNG
18.19.1 COMPANY SNAPSHOT
18.19.2 REVENUE ANALYSIS
18.19.3 PRODUCT PORTFOLIO
18.19.4 RECENT DEVELOPMENTS
18.2 SHENXHEN ANKE HIGH-TECH CO., LTD.
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENT
18.21 SHIMADZU CORPORATION
18.21.1 COMPANY SNAPSHOT
18.21.2 REVENUE ANALYSIS
18.21.3 PRODUCT PORTFOLIO
18.21.4 RECENT DEVELOPMENTS
18.22 SIUI
18.22.1 COMPANY SNAPSHOT
18.22.2 PRODUCT PORTFOLIO
18.22.3 RECENT DEVELOPMENTS
18.23 STERNMED GMBH
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 STRYKER
18.24.1 COMPANY SNAPSHOT
18.24.2 REVENUE ANALYSIS
18.24.3 PRODUCT PORTFOLIO
18.24.4 RECENT DEVELOPMENTS
18.25 TERASON DIVISION TERATECH CORPORATION
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
表格列表
TABLE 1 EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 2 EUROPE MODERATE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 3 EUROPE SEVERE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 EUROPE MILD IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 EUROPE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 6 EUROPE COMPUTED TOMOGRAPHY (CT SCAN) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 EUROPE COMPUTED TOMOGRAPHY ANGIOGRAPHY (CTA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 8 EUROPE MAGNETIC RESONANCE IMAGING (MRI) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 EUROPE MAGNETIC RESONANCE ANGIOGRAPHY (MRA) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 10 EUROPE TRANSCRANIAL DOPPLER ULTRASOUND IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 11 EUROPE VIDEO HEAD IMPULSE TEST (VHIT) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 14 EUROPE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 15 EUROPE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 16 EUROPE ISCHEMIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 17 EUROPE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 18 EUROPE HEMORRHAGIC STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 19 EUROPE TRANSIENT ISCHEMIC ATTACKS (TIAS) IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 EUROPE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 21 EUROPE HOSPITAL IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 EUROPE CLINICS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 EUROPE AMBULATORY SURGICAL CENTERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 EUROPE HOME HEALTHCARE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 EUROPE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 EUROPE DIRECT TENDER IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 EUROPE THIRD PARTY DISTRIBUTORS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 EUROPE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 31 EUROPE PRE OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 32 EUROPE PERI OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 33 EUROPE POST OPERATIVE IN STROKE DIAGNOSTICS MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 34 EUROPE STROKE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 35 EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 36 EUROPE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 37 EUROPE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 EUROPE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 39 EUROPE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 40 EUROPE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 41 EUROPE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 42 EUROPE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 43 EUROPE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 44 GERMANY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 45 GERMANY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 GERMANY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 47 GERMANY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 48 GERMANY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 49 GERMANY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 50 GERMANY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 51 GERMANY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 52 GERMANY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 53 FRANCE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 54 FRANCE STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 55 FRANCE OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 FRANCE STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 FRANCE ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 58 FRANCE HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 59 FRANCE STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 FRANCE STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 FRANCE STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 62 U.K. STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 63 U.K. STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 64 U.K. OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 65 U.K. STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 66 U.K. ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 U.K. HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 68 U.K. STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 69 U.K. STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 70 U.K. STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 71 ITALY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 72 ITALY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 73 ITALY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 74 ITALY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 75 ITALY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 76 ITALY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 ITALY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 78 ITALY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 79 ITALY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 80 SPAIN STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 81 SPAIN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 82 SPAIN OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 83 SPAIN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 84 SPAIN ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 85 SPAIN HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 86 SPAIN STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 87 SPAIN STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 88 SPAIN STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 89 RUSSIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 90 RUSSIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 91 RUSSIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 92 RUSSIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 93 RUSSIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 94 RUSSIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 95 RUSSIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 96 RUSSIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 97 RUSSIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 98 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 99 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 100 NETHERLANDS OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 101 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 102 NETHERLANDS ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 103 NETHERLANDS HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 104 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 105 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 106 NETHERLANDS STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 107 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 108 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 109 SWITZERLAND OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 110 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 111 SWITZERLAND ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 112 SWITZERLAND HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 113 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 114 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 115 SWITZERLAND STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 116 TURKEY STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 117 TURKEY STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 118 TURKEY OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 119 TURKEY STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 120 TURKEY ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 121 TURKEY HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 122 TURKEY STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 123 TURKEY STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 124 TURKEY STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 125 AUSTRIA STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 126 AUSTRIA STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 127 AUSTRIA OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 128 AUSTRIA STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 129 AUSTRIA ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 130 AUSTRIA HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 131 AUSTRIA STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 132 AUSTRIA STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 133 AUSTRIA STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 134 BELGIUM STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
TABLE 135 BELGIUM STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 136 BELGIUM OTHERS IN STROKE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 137 BELGIUM STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 138 BELGIUM ISCHEMIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 139 BELGIUM HEMORRHAGIC STROKE IN STROKE DIAGNOSTICS MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 140 BELGIUM STROKE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 141 BELGIUM STROKE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 142 BELGIUM STROKE DIAGNOSTICS MARKET, BY STAGE, 2019-2028 (USD MILLION)
TABLE 143 REST OF EUROPE STROKE DIAGNOSTICS MARKET, BY SEVERITY, 2019-2028 (USD MILLION)
图片列表
FIGURE 1 EUROPE STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 2 EUROPE STROKE DIAGNOSTICS MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE STROKE DIAGNOSTICS MARKET: DROC ANALYSIS
FIGURE 4 EUROPE STROKE DIAGNOSTICS MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE STROKE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE STROKE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE STROKE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE STROKE DIAGNOSTICS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 EUROPE STROKE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE STROKE DIAGNOSTICS MARKET: SEGMENTATION
FIGURE 11 THE INCREASE IN DEMAND FOR STROKE DIAGNOSTISIS EXPECTED TO DRIVE THE EUROPE STROKE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE STROKE DIAGNOSTICS MARKET IN 2021 & 2028
FIGURE 13 NORTH AMERICA IS EXPECTED TO DOMINATE THE EUROPE STROKE DIAGNOSTICS MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE EUROPE STROKE DIAGNOSTICS MARKET
FIGURE 15 EUROPE STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020
FIGURE 16 EUROPE STROKE DIAGNOSTICS MARKET: BY SEVERITY, 2020-2028 (USD MILLION)
FIGURE 17 EUROPE STROKE DIAGNOSTICS MARKET: BY SEVERITY, CAGR (2021-2028)
FIGURE 18 EUROPE STROKE DIAGNOSTICS MARKET: BY SEVERITY, LIFELINE CURVE
FIGURE 19 EUROPE STROKE DIAGNOSTICS MARKET: BY TYPE, 2020
FIGURE 20 EUROPE STROKE DIAGNOSTICS MARKET: BY TYPE, 2020-2028 (USD MILLION)
FIGURE 21 EUROPE STROKE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)
FIGURE 22 EUROPE STROKE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 23 EUROPE STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020
FIGURE 24 EUROPE STROKE DIAGNOSTICS MARKET: BY APPLICATION, 2020-2028 (USD MILLION)
FIGURE 25 EUROPE STROKE DIAGNOSTICS MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 26 EUROPE STROKE DIAGNOSTICS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 27 EUROPE STROKE DIAGNOSTICS MARKET: BY END USER, 2020
FIGURE 28 EUROPE STROKE DIAGNOSTICS MARKET: BY END USER, 2020-2028 (USD MILLION)
FIGURE 29 EUROPE STROKE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)
FIGURE 30 EUROPE STROKE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE
FIGURE 31 EUROPE STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 32 EUROPE STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020-2028 (USD MILLION)
FIGURE 33 EUROPE STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 34 EUROPE STROKE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 35 EUROPE STROKE DIAGNOSTICS MARKET: BY STAGE, 2020
FIGURE 36 EUROPE STROKE DIAGNOSTICS MARKET: BY STAGE, 2020-2028 (USD MILLION)
FIGURE 37 EUROPE STROKE DIAGNOSTICS MARKET: BY STAGE, CAGR (2021-2028)
FIGURE 38 EUROPE STROKE DIAGNOSTICS MARKET: BY STAGE, LIFELINE CURVE
FIGURE 39 EUROPE STROKE DIAGNOSTICS MARKET: SNAPSHOT (2020)
FIGURE 40 EUROPE STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020)
FIGURE 41 EUROPE STROKE DIAGNOSTICS MARKET: BY COUNTRY (2021 & 2028)
FIGURE 42 EUROPE STROKE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)
FIGURE 43 EUROPE STROKE DIAGNOSTICS MARKET: BY SEVERITY (2021-2028)
FIGURE 44 STROKE DIAGNOSTICS MARKET COMPANY SHARE 2020 (%)
研究方法
数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息，请请求分析师致电或下拉您的询问。
DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析和主要（行业专家）验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息，请向我们的行业专家咨询。
可定制
Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制，包括目标品牌的价格趋势分析、了解其他国家的市场（索取国家列表）、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表（事实手册）中的数据，或者可以帮助您根据报告中的数据集创建演示文稿。
